Schrodinger inc.

Other-Pharmaceuticals

SDGR


Executive/
Director

Price

  • Last Close
  • $ 20.88
    $ +0.46 2.25 %
    Jan 3, 2025
  • 52-Week High/Low
  • $37.21 - $18.6
  • YTD
  • 0%

  • Trading Volume
  • 17,148
  • Market Cap Full
  • $ 1.5B
  • Shares Outstanding
  • 71.5M
    Mar 31, 2023
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Q1 - - - -5% -4.6% -2.2% 40.9% -24.6% 8.3% -
Q2 - - - 4% -1% -22.6% 89.6% -26.1% - -
Q3 - - - 8% -27.7% -5.4% -43.4% -10.2% - -
Q4 - - - 64.9% -36.2% -25.2% 30.1% -11% - -
J F M A M J J A S O N D
2026 - - - - - - - - - - - -
2025 8.3% - - - - - - - - - - -
    2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
    0%0%0%0%0%-56%-46%92%-46%8%0%

Earnings

2017 2020 2021 2022 2023
Q1 - - - -0.48 1.75
Q2 - - -0.49 -0.67 0.06
Q3 - - -0.49 -0.56 -0.86
Q4 - - -0.44 -0.39 -
A 0 -0.4 -1.4 -2.1 0.95

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2019 2020 2021 2022 2023
Mar - - - 71.1 71.5
Jun - - 70.6 71.2 -
Sep 44.9 66.3 70.8 71.2 -
Dec - 60 70.6 71.2 -

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - 1.7 2.3 -
Total Asset Turnover - - 0.1 0.6 -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage - - 1.7 2.7 -
Equity multiplier 0.1 0.1 0.1 0.2 0.2